Treatment of systemic lupus erythematosus (SLE) with severe diffuse proliferative nephritis is often challenging, particularly in small children in whom a genetic conditioning is likely to play a role. The effectiveness of standard therapy based on glucocorticoid and immunosuppressive drugs is often unsatisfactory.

Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy

Peruzzi L;MARTINO, Silvana;TOVO, Pier Angelo;
2015-01-01

Abstract

Treatment of systemic lupus erythematosus (SLE) with severe diffuse proliferative nephritis is often challenging, particularly in small children in whom a genetic conditioning is likely to play a role. The effectiveness of standard therapy based on glucocorticoid and immunosuppressive drugs is often unsatisfactory.
2015
30
1
167
172
Systemic lupus erythematosus; Lupus nephritis; Treatment; Eculizumab; C5 inhibition; Atypical hemolytic uremic syndrome; Treatment-resistant SLE
Coppo R; Peruzzi L; Amore A; Martino S; Vergano L; Lastauka I; Schieppati A; Noris M; Tovo PA; Remuzzi G
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/152563
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 63
  • ???jsp.display-item.citation.isi??? 56
social impact